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Abstract
Introduction: Poor antiretroviral therapy (ART) adherence can create a dangerous
public health problem and limits the effectiveness of human immunodeficiency virus
treatment. Since adherence status is dynamic, information is needed to identify site
specific determinants of non-adherence to antiretroviral therapy for effective
intervention methods.
Objective: The objective of the study was to identify determinants of non-adherence
to antiretroviral therapy among adults on ART in Aksum town health facilities
Methods: An Institution based unmatched case control study was conducted from
March 20 to May 15/2015 among 411 adult PLWHA (137 cases and 274 controls).
Systematic random sampling was used to select controls and all cases were
included (cases were rare). Data was collected by both document review and
interview via structured and pretested questionnaire. Both bi-variable and multiple
logistic regressions were used to compute the statistical test associations by STATA
version12.Variables with p – value < 0.05 were considered as statistically significant.
Results: Sixty nine (58.1%) from non-adherents and 170(62%) from adherents were
males on ART for more than 6 months. More than two years duration on ART
(AOR=7 and 95% CI=2.2-22.6), experiencing ART adverse effect (AOR=6.9 and
95% CI=1.4-32.9), substance use (AOR=5.3 and 95% CI=1.4-20.0),living with
parents (AOR=3.4 and 95% CI =1.2-10.3), having depression symptom(AOR=3.3
and 95% CI=1.4-7.5), less than 350 cells / mm3 CD4 count (AOR=3.2 and 95%
CI=1.8-5.8) and low dietary diversity (AOR=2 and 95%CI=1.1-3.7) were found to be
at higher risk of non-adherence .
Conclusion: Long duration on ART, experiencing adverse effect of ART, substance
use, living with parents, having depression symptom, low CD4 cell count and low
dietary diversity were identified as a risk factors for non-adherence to ART. For
those PLWHA who stayed on ART for long duration, health care providers have to
give much attention to client’s situation on following ART.
Key words: Antiretroviral therapy, case control study, determinant factors, Ethiopia
11. INTRODUCTION
1.1. Statement of the problem
Globally there were 35 million people living with Human Immunodeficiency Virus/
Acquired Immune Deficiency Syndrome (HIV/AIDS) in 2013. There were an
estimated 24.7 million [23.5–26.1 million] people living with HIV in Sub-Saharan
Africa, nearly 71% of the global total (1). In Ethiopia In 2013 there were an estimated
793,700(716,300-893,200) people living with HIV/AIDS(2).
Antiretroviral therapy (ART) has played an important role in improving the prognosis
and quality of life of HIV/AIDS patients, in reducing the rate of disease progression
and death (3). Worldwide almost 12.9 million people were receiving ART at the end
of 2013. Only 38% of adults living with HIV had access to ART treatment. Three of
four people receiving HIV treatment were living in sub-Saharan Africa. 22 million, or
three of five people living with HIV were not accessing ART (1).
Adherence to treatment is critical to obtain full benefits of ART including maximum
and durable suppression of viral replication, reduced destruction of CD4 cells,
prevention of viral resistance, promotion of immune reconstitution, and slowed
disease progression (4). At least 95% adherence is required for ART regimens to be
fully effective and to avoid the emergence of resistant strains of the virus (5, 6).Poor
ART adherence can create a dangerous public health problem and limit the
effectiveness of available HIV treatments (7). However both patients and health care
providers face significant challenges with respect to adherence to ART (6).
In 2012, over 9.7 million people living with HIV in low- and middle-income countries
were receiving ART (8). However, ensuring adherence to HIV treatment remains
challenging in all countries. Adherence is a complex behavior, which is influenced by
several determinants (5). A meta-analysis of patients in North America (n = 17 573)
and Africa (n = 12 116) estimated that only 55% and 77% in these areas, respectively,
achieved over 80% adherence (9). A 2011 meta-analysis, which pooled ART
adherence of 33 199 adults in 84 observational studies, reports that only 62% of
2individuals took at least 90% of their prescribed ART doses (10). Depending on the
drug under study, adherence to ARV varies between 37 to 83 percent (11).
In Ethiopia by the end of June 2013 the number of people ever enrolled in chronic care
reached 728,874 while the number ever started ART was 439,301(2) and 343,600
were currently receiving ART(12) . Only 70.3% of individuals who ever started ART
were currently on treatment. However, patient loss to follow-up and ensuring
adherence to ART regimens remain major challenges of the ART programme (2).
Despite free ART services has been one of the greatest achievements and ART
programme services have expanded on a large scale, adherence rate were reported
below 95% due to different factors associated with non-adherence to ART (5, 13, 14).
In Ethiopia as identified by different studies availability of reminder, alcohol
consumption, malnutrition, dietary diversity, CD4 count, depression symptom, adverse
effect of ART  and duration on ART were factors associated with non-adherence to
ART (5, 13, 15-17). Duration on ART in Lao PDR and Nepal: (18, 19) and CD4 count in
Southern Ethiopia and systematic review in Cameroon (17, 20) were controversial on
their association to ART adherence.
Adherence is not stable. Therefore evidence based information is needed to identify
factors associated with non-adherence to ART in the study area.
31.2. Literature review
1.2.1. Socio demographic factors
systematic review in Cameroon showed  female gender was found at less probability
of being non-adherence (20).But In Nepal and Zambia females non-adherence were
found higher than males (19, 21). In southern Ethiopia females  were 67.8% less
likely at risk of non-adherence to ART than male patients(22).
Systematic review in Cameroon and  cross sectional study in India found higher  age
was associated with decreasing non-adherence level (20, 23). Studies in Nigeria and
Kenya showed age, did not associated with non-adherence (24, 25).
In Senegal respondents who were  singles tend to complied better adherence than
other groups(26). However, in Nepal, Kenya and Ethiopia, no significant association
was found between marital status and non-adherence to ART (14, 25, 27).
Study in Lao PDR and Systematic review in Cameroon reported that  those who
had higher educational level were less non-adherent  than that of lower level of
education (18, 20). Similarly study conducted in Nepal identified  being illiterate was
4.58 times increased likelihood of non-adherence to ART (19).
Meta-analysis included 28 studies involved 8743 HIV-infected individuals from
each14 developing and  developed countries showed  patients with HIV infections
who were employed were 27% less likely non-adherent to ART than those who were
unemployed (28).
Those who live far away  to treatment centre  were more likely to be non-adherent
than their counter parts (19). However  in Kenya respondents who accessed therapy
in clinics within a walking distance were more likely non- adherent than patients who
refilled in far away clinics (25).
41.2.2. Psychosocial factors
In southwest and eastern Ethiopia patients who had no family and social support
were more likely to be none-adherent to ART as compared to those who get support
from their family, religious and social organizations(17, 22).
In Canada individuals living with someone were less non-adherent than compared
with those live alone(29). But in Nairobi Kenya, living with family/parents/alone did
not show significant association with non-adherence to ART treatment (25).
As study reported in Togo PLWHA who disclosed their HIV status to their sexual
partners were less likely to be non-adherent to ART than that of not disclosed their
HIV status(30). In Tanzania and Ethiopia, Debremarkos Hospital, participants who
disclosed their HIV status were less likely non-adherent to regimens as compared
with their counter parts(5, 31).
A meta-analysis in Netherlands and study in South Africa and southwest Ethiopia
showed that patients who did not have depressive symptoms had less probability of
being non-adherent compared to their counterpart (15, 32-34).
Studies in Nepal, Tanzania and Southern Ethiopia reported that those who drank
alcohol were non-adherent to their ART medication than those who did not drink
alcohol (17, 19, 31).
1.2.3. Medication related factors
As studies reported in Asian developing countries in 2012 ART drugs have toxicities
and adverse side-effects that can facilitate non-adherence(35). Moreover studies in
Nepal, northwest Ethiopia reported that those who had ART adverse effects were
non-adherent to ART than that of without adverse effects of ART(13, 19).
Those who took ART for a long duration were more non-adherent than those of who
staid short period on ART(18). Similarly in Ethiopia ( Debremarkos and Yirgalem
Hospitals) the respondents’ non-adherence rate was inversely proportional to the
length of time they had been on ART(5, 22).Findings of prospective study in Asia
5and mixed method in Nepal showed that patients who have been on ART for short
period  (less than two years) were more likely to be non-adherent(19, 36).
In Nepal those who had history of illegal drug use were nearly four times non-
adherent than their counter parts (27) . Traditional medicines was also negatively
associated with non-adherence to ART in Nigeria(24).
Study in Delhi India revealed that the presence of opportunistic infection was
significantly associated with decreasing non-adherence to ART(37). But in south
Ethiopia Opportunistic infection did not show significant association with  non-
adherence to ART (17).
As study reported from south Ethiopia no significant association was found between
WHO staging and ART non-adherence (17).
In Nepal study illustrates strong association between the use of reminder tools and
increasing ART adherence(10). Similarly in south Ethiopia  Participants who has no
mobile phone were more likely to be none adherent to ART as compared to their
counterpart(17).
1.2.4. Nutrition related factors
In Cape Town, South Africa; food insecurity/insufficiency was a threat to adherence
(38). Study in Zambia, south and north Ethiopia also revealed that dietary diversity
was positively associated with improving treatment adherence (16, 17, 21). In south
Ethiopia meal frequency did not showed significant association with non-adherence
to ART (17). In north and southern Ethiopia those who had  less Body Mass Index
(BMI) were non-adherent to ART as compared to with that of with large BMI (16, 17).
1.2.5. Immunological related factors
Systematic review in Cameron and cross sectional study in South Africa showed that
those with higher CD4 cell counts had significantly lower non-adherence rates as
compared to patients having lower CD4 cell count(20, 33). Similar findings were
reported in south and north Ethiopia (16, 17). Controversial  to the above in Yirgalem
6Hospital patients who had high CD4 counts were more likely at risk of non-
adherence to ART than those who had less  CD4 count (22).
Among the most commonly identified factors for ART non-adherence are, duration
on ART, opportunity infection, adverse effect of ART, dietary diversity,BMI,CD4 cell
count, social support, alcohol consumption, depression symptom, and  availability of
reminder were factors associated with non-adherence to ART (5, 13, 15-17). But
duration on ART between studies in Ethiopia(Debremarkos and Yirgalem hospitals)
(Asmare et al., 2014, Irano et al., 2015) and Nepal (19)and CD4 count between
South and North Ethiopia(16, 17) and Yirgalem Hospital (Irano et al., 2015) were
showed controversial association with ART adherence status.
7Conceptual framework
Based on the different literatures reviewed (5, 6, 15-17, 31, 39) the following
conceptual framework was adopted.
Figure 1: Conceptual framework for determinants of non-adherence to antiretroviral
therapy among HIV- Infected adults in Aksum town health facilities, Ethiopia 2015
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81.3. Justification of the study
Human immune deficiency virus poses a unique challenge due to its rapid replication
and mutation rates. Despite antiretroviral medications control HIV virus replication or
multiplication, successful HIV therapy requires adherence greater than 95% to
achieve long term suppression of viral load(6). However taking ART medicines life-
long treatment is one of the biggest challenges and non-adherence remains a major
concern due to different factors. Adherence is a dynamic process on which
adherence status changes over time and is influenced by multiple factors.
Controversial association of variables with adherence status was reported (duration
on ART between studies in Ethiopia (Asmare et al., 2014, Irano et al., 2015)) and
Nepal (Wasti et al., 2012) and CD4 count between studies in south and north
Ethiopia (Bitew et al., 2014, Berhe et al., 2013) and in Yirgalem Hospital (Irano et al.,
2015)).
In Tigray Region as well as Aksum town, little is known on factors associated with
non-adherence to ART and since adherence is not stable, evidence based
information is needed to identify site specific determinants of non-adherence to ART
and to plan effective intervention strategies. Therefore this study could help to
identify determinant of non adherence to ART in Aksum town health facilities and
can be used for planning interventions to maximize long-term adherence for clients
on ART.
92. OBJECTIVE OF THE STUDY
The objective of the study was to identify determinants of non-adherence to
Antiretroviral Therapy among HIV infected adults on ART in Aksum town.
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3. METHODS
3.1. Study design and period
An Institution based unmatched case control study was carried out from March 20 to
May 15/2015. Non-adherence to ART was considered as case and adherence to
ART was taken as control.
3.2. Study setting
The study was conducted in Aksum town health facilities which are found in Aksum
town, Tigray Regional State of Ethiopia. Aksum is located 1067 K/m north of Addis
Ababa which is the capital City of Ethiopia. The town has a total population of 60706.
In Aksum town there are one referral hospital (Aksum St. Marry hospital) and one
health center (Aksum health center) that gives ART service. There were 2764 adults
ever enrolled to ART (2293 in Aksum St. Marry hospital and 471 in Aksum health
center). Currently 1351 HIV infected adults (1143 in Aksum St.Marry hospital and
208 in Aksum health center)  are on ART (40).
3.3. Source and study population
Source /study population for cases and controls were all HIV/AIDS positive adults on
ART in Aksum town health facilities
3.4. Sample size
The sample size was computed by EpI-Info version7 for un-matched case control
study by considering the following assumptions: α= 5%, power = 80%, proportion of
controls exposed = (12.1%), proportion of cases expose =21.7%, OR= 2.18 and
case to control ratio= 1:2 (Table1).
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Table 1: Sample size determination for factors associated with ART non-adherence
Determinant of non-
adherence to ART
%
controls
exposed
OR %
cases
exposed
Case to
Control
Ratio
Sample     size
Cases Controls
CD4 cell count less than
250 cells/mm3 (17)
12.1 2.18 21.7 1 :2 130 260
Unable to get enough food
/Low dietary diversity (16)
46 2.1 68.4 1 :2 95 190
BMI ≤18.5 kg/m2(17) 15.3 2.83 14.8 1 :2 61 122
To maximize the sample, by adding 5 % non-response, 137cases and 274 controls
final samples were used. Three main variables were used to estimate sample size
from previous studies (16, 17). One to two ratio of case to control was taken
considering source of cases and controls (because of small number of cases).
3.5. Sampling procedure
From ART follow up charts, all cases that came to ART clinic during data collection
period according to their appointment were included in the study and for those who
fail to come to health institutions (HI) during their appointment were tried to be traced
by phone by their case managers. Controls were selected by using systematic
random sampling method. The sampling interval for controls was 4 obtained by
dividing the total number of controls to the total sample size of controls. The first
participant was selected at random using lottery method from 1, 2, 3 and 4. Then
two was selected as a starting point. This method continued until we got 274
controls. Finally data was collected from 137 cases and 274 controls.
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Sampling procedure
Figure 2: Sampling procedure for selecting adults on ART in Aksum town health
facilities, Tigray Regional State, Ethiopia 2015.
3.6. Inclusion criteria
All adults’ on ART receiving antiretroviral therapy at Aksum St.Marry hospital and
Aksum health center for six months or more and those with complete data  in the
individual charts (e.g. CD4 count, WHO staging and ART adverse effect) were
included in the study.
Aksum town =1351 adults on ART
Aksum health center
Cases=22 & Controls= 180
Aksum St.Marry hospital
Cases=143 & Controls=1000
Total sample size
Case=137 & Control=274
Case=18 &Controls=42Cases=119 & Controls=232
Using Proportional allocation formula
All cases were included & for controls systematic
random sampling technique were used
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3.7. Study variables
Dependent variable: non-adherence to ART
Independent variables includes
Socio-demographic and economic factors: - age, sex, religion, marital status,
educational status, occupation, income and residence
Psychosocial factors: - Depression, social support, disclosure of sero-status and
substance use (alcohol use, cigarette smoking and chat chewing).
Medication and clinical related factors: - Recent WHO staging, opportunistic
infection, ART adverse effect, duration on ART treatment, illegal drug use and use of
reminder
Nutrition/feeding related factors: - BMI of the recent last three visits dietary diversity
within the last 24 hours and feeding frequency of the last one year.
Immunological factor: - Recent CD4 count of the last three visit
3.8. Operational definition of variables
Non-adherence to ART: The condition of missing doses completely, not following
information given by a physician, as well as taking drugs inappropriately. Which
means taking doses two or more hours before, and/or two or more hours after the
time of a doctor’s advice to take doses or missing doses completely (less than 95%
adherence = missing >2 doses of 30 doses or >3 doses of 60 doses)(16, 17)
Adherence to ART: - Is defined as taking one’s medicine as prescribed and agreed
between the patient and provider which is 95% or more adherences to ART. Which
means taking doses no more than two hours before or two hours after the time of a
doctor’s advice to take doses (95% or more adherence = missing ≤2 doses of 30
doses or ≤3 doses of 60 doses) (16, 17).
Dietary diversity: The number of reported different foods and food groups
consumed in a household over a 24- hour period. This does not include food group
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consumed outside home. It is classified as low if < 3 food items consumed, medium
if 4-6 food items consumed and high if ≥6 food items consumed (41).
Body mass index (BMI): A measure of weight adjusted for height, calculated as
weight in kilograms divided by the square of height in meters (kg/m2).Classified as
underweight (BMI<18.5 kg/ m2), normal (18.5 ≥BMI<25 kg/m2) and overweight or
obese (BMI ≥25)(42).
Depression: Classified  by patient health questionnaire (PHQ) with 9-items on
which  score ranges from 0 to 27,depression  was classified as a score of 1 to 4-no
depression, 5 to 9 mild depression, 10 to 14 moderate depression, 15 to 19-
moderately severe depression and 20 to 27 severe depression, (43).
Social support: If a client had any material/financial, advice/information and social/
moral supports from any individual or organization during the last three visits of
chronic follow-up.
Living condition: living with parents for clients who live with their mothers and
fathers and living with family for clients who live with their spouse and children.
3.9. Data collection procedure
Data was collected by both document review (such as adherence status, sex, CD4
cell count, adverse effect of ART, WHO staging, duration on ART, BMI, opportunistic
infection and dose per day) and face to face interview (such as age, residence,
marital status, educational status, occupation, reminder use, dietary diversity, eating
pattern, depression, stigma, substance use and living condition). A structured and
pre-tested questionnaire was developed from different literatures. The questionnaire
was first developed in English and translated to the local language Tigrigna (all were
Tigrigna speakers) and then translated back to English by different interpreters to
check for its consistency. Secondary data were extracted from ART registration
follow up charts using data abstraction format. The principal investigator and two
BSC nurses as supervisor and two diploma nurses and three case managers as
data collectors were participated in the data collection.
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3.10. Data quality control
In order to ensure quality of data, pre testing of the questionnaire was done on 21
clients(5% of the total sample size) prior to the actual study on clients on ART in
Wukro Maray health center which is 15 K/M from Aksum town and necessary
modification was done for the questionnaire according to the gap identified.
One day intensive training was given for data collectors and supervisors on how to
approach the clients and how to collect data from ART registration charts. Interview
of participants was carried out in private room. Data collection process was strictly
followed day to day by the principal investigator and supervisors and the collected
data was checked for completeness and consistency every day and any gaps
identified were communicated to the data collector. Before analysis, data cleanup
and cross check was done.
3.11. Data management and analysis
After the data was checked for its consistency and completeness, it was entered into
EPI-INFO version 3.5.1 and was exported to STATA Version 12 for analysis. Data
was entered by the principal investigator and was cleaned before analysis. Summary
statistics were carried out to describe study participants in relation socio-
demographic and economic variables. Continuous variables were summarized using
mean and standard deviation (SD). Categorical variables were also presented using
proportions and tables.
Both bivariable and multivariable analysis were used to identify determinants of non-
adherence to ART among HIV infected adults. Co-linearity diagnostic test was
conducted using tolerance to check for co-linearity between independent variables
and interaction effect was also checked. Finally factors that showed association in
bivariable analysis and which had P-value less than 0.2 were entered in to multiple
logistic regression model. Strength of the study was assessed using OR with 95%
CI. Model fitness was also checked by using Hosmer–Lemeshow goodness-of-fit
test (p-value= 0.9289>0.05 suggests the model fits the data well). At the end
adjusted odds ratio with 95% CI and P-value <0.05 was considered as statistically
significant.
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4. ETHICAL CONSIDERATION
Ethical clearance was obtained from Review Board of institute of public health,
collage of Medicine and Health Science, University of Gondar. An official permission
letter was obtained from Aksum St.Marry hospital and Aksum health center. During
data collection written consent was obtained from each participant after they were
introduced the purpose and importance of the study. Participant’s involvement in the
study was on voluntary basis and they were informed about their rights to interrupt
the interview at any time for those who need to stop their participation. To ensure
confidentiality, all of the study participants were assured that the data will be
anonymous, name or any other personal identifiers will not be recorded and that was
done according the consent.
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5. RESULTS
5.1. Socio demographic and economic characteristics
One hundred thirty seven non-adherents (cases) and 274 adherents (controls) that
were on ART for at least 6 months prior to the study were included in the study. Sixty
nine (58.1%) from non-adherents and 170 (62%) from adherents were males and
the mean age ± (SD) of non-adherents and adherents were 37.21±9.95 and 35±8.85
years respectively. Majority, 60 (43.8%) of non-adherents and 127(46.4) adherents’
age range were 30-39 years. One hundred fourteen (83.2%) non-adherents and
253(92.3%) adherents were urban residents (table2).
Table 2: Socio demographic and economic characteristics of HIV infected adults on
ART in Aksum town health facilities, Tigray Regional State, Ethiopia 2015.
Variables/categories Adherence status to ART treatment
Non-adherent
Number (%)
Adherent
Number (%)
Sex
Male 69(50.4) 170(62)
Female 68(49.6) 104(38)
Age
18-29 23(16.8) 54(19.7)
30-39 60(43.8) 127(46.4)
40-49 35(25.5) 74(27.0)
>=50 19(13.9) 19(6.9)
Mean(SD) 37.21(9.95) 35(8.85)
Religion
Orthodox 127(92.7) 235(85.7)
Muslim 9(6.6) 38(13.9)
Catholic 1(0.7) 1(0.4)
Ethnicity
Tigray 137(100) 273(99.6)
Amhara 0 1(0.4)
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Table 2(Continued): Socio demographic and economic characteristics of HIV
infected adults on ART in Aksum town health facilities, Tigray, Ethiopia 2015.
Variables/categories Adherence status to ART treatment
Non-adherent
Number (%)
Adherent
Number (%)
Marital status
Single 25(18.2) 47(17.2)
Married 64(46.7) 128(46.7)
Widowed 14(10.2) 32(11.7)
Divorced/separated 34(24.8) 67(24.4)
Residence
Urban 114 (83.2) 253(92.3)
Rural 23(16.8) 21(7.7)
Educational level
No formal education 29(21.2) 57(20.8)
Primary education(1-8) 68(49.6) 128(46.7)
Secondary education(9-12) 33(24.1) 69(25.2)
12+ 7(5.1) 20(7.3)
Occupation
no occupation 21(15.3) 42(15.3)
government employed 25(18.3) 52 (19)
business/self employed 40(29.2) 96(35)
Farmer 14(10.2) 10(3.7)
Daily laborer 37(27) 74(27)
Monthly income in ETB
<=500 46(33.6) 110(40.2)
501-750 23(16.8) 27(9.8)
751-1000 38(27.7) 66(24.1)
>=1001 30(21.9) 71(25.9)
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5.2. Determinants of non-Adherence to antiretroviral therapy
In the bivariable analysis; sex, age, residence, occupation, living condition,
substance use, duration on ART, ART adverse effect , depression, dietary diversity,
eating pattern, opportunistic infection, treatment other than ART, reminder use,
WHO stage, BMI and CD4 count were significantly associated with non-adherence.
During the multivariable analysis duration of treatment, ART adverse effect,
substance use, living condition, depression, CD4 cell count and dietary diversity had
showed significant association with non-adherence to ART
Those who were on ART  for more than two years had 7 times more likely being
non-adherence compared to those have been on ART for 6-12 months (AOR=7 and
95% CI=2.2-22.6).
Study participants who experienced ART adverse effect were 6.9 times more likely
to be non-adherents compare to those who did not had any adverse effect(AOR=6.9
and 95% CI=1.4-32.9).
Substance use was 5.3 times more likely among non-adherents compared to
adherents (AOR=5.3 and 95% CI= 1.4-20.0).
Non-adherence was 3.4 times more likely to occur among those who live with their
parents compared to those who live alone (AOR=3.4 and 95%CI = 1.2-10.3).
Those who had depression symptom were 3.3 times more likely to be non-adherent
when compared to those who had not depression (AOR=3.3 and 95% CI=1.4-7.5).
The odds of non-adherence was 3.2 times higher among HIV-infected adults with
CD4 cell cont less than 350 cells/mm3 compared to HIV-infected adults with CD4 cell
count greater than or equals to 350 cells/mm3 (AOR=3.2  and 95% CI=1.8-5.8)
Those who eat low dietary diversity had two times higher odds of being non-
adherence compared to those who eat medium and above dietary diversity (AOR=2
and 95% CI =1.1-3.7)
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Table 3: Determinants of non-adherence to ART among HIV-infected adults at
Aksum town health facilities, Tigray Regional State, Ethiopia 2015
Explanatory
variables
Adherence status to ART COR(95%CI) AOR(95%CI)
Non-adherent
Number (%)
Adherent
Number (%)
Sex
Male 69(50.4) 170(62) 1 1
Female 68(49.6) 1o4(38) 1.6(1.1-2.4) 1.4(0.8-2.4)
Age
18-29 23(16.8) 54(19.7) 1 1
30-39 60(43.8) 127(46.4) 1.1(0.6-2.0) 1.1(0.5-2.4)
40-49 35(25.5) 74(27) 1.1(0.6-2.1) 0.7(0.3-1.7)
>=50 19(13.9) 19(6.9) 2.3(1.1-5.2) 1.7(0.6-5.0)
Residence
Urban 114(83.2) 253(92.3) 1 1
Rural 23(16.8) 21(76.7) 2.4(1.3-4.6) 1.4(0.5-4.0
Occupation
no occupation 21(15.3) 42(15.3) 1 1
Employed 25 (18.3) 52   (19) 0.9(0.5-2) 1.4(0.5-4.2)
Business 40(29.2) 96(35) 0.8(0.4-1.6) 1.8(0.7-4.0)
Farmer 14(10.2) 10(3.7) 2.8(1.1-7.4) 2.3(0.5-10.3)
Daily laborer 37(27) 74(27) 1(0.5-1.9) 1.9(0.8-4.7)
Duration on ART
6-12 month 7(5.1) 38(13.9) 1 1
13-24 month 14(10.2) 38 (13.9) 2.0(0.7- 5.5) 2(0.5-8.8)
>=25 month 116(84.7) 198(72.2) 3.2(1.4   7.4) 7(2.2,22.6)**
ART adverse effect
Yes 26(19) 3(1.1) 21.2(6.3-71.3) 6.9(1.4,32.9)**
No 111(81) 271 (98.9) 1 1
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Table 3(Continued): Determinants of non-adherence to ART among HIV-infected adults
in Aksum town health facilities, Tigray Regional State Ethiopia 2015.
Explanatory
variables
Adherence status to ART COR(95%CI) AOR(95%CI)
Non-adherent
Number (%)
Adherent
Number (%)
Substance use
Yes 21(15.3) 5(1.8) 9.7(3.6-26.5) 5.3(1.4-20.0)**
No 116(84.7) 269(98.2) 1 1
Live with
Alone 33(24.1) 83(30.3) 1 1
Parents 18(13.1) 21(7.7) 2.2(1.02-4.6) 3.4(1.2-10.3)**
Family 86(62.8) 170(62) 1.3(0.8-2.1) 1.5(0.8-2.8)
Depression status
Depressed 41(29.9) 19 (6.9) 5.7(3.2-10.4) 3.3(1.4-7.5)**
Not depressed 96(70.1) 255(93.1) 1 1
CD4 cel count
<350 cells/mm3 58(42.3) 45 (16.4) 3.7(2.4-6.0) 3.2(1.8-5.8)**
>=350 cells/mm3 79(57.7) 229 (83.6) 1 1
Dietary diversity
Low 57(41.6) 43(15.7) 3.8(2.4-6.1) 2(1.1-3.7)**
Medium & above 80(58.4) 231(84.3) 1 1
Daily eating pattern
<= Two meals 69(50.4) 103(37.6) 1.7(1.1-2.6) 1.01(0.6-1.8)
>=three meals 68(49.6) 171(62.4) 1 1
OI
Yes 28(20.4) 5(1.8) 13.8(5.2-36.7) 3.6(1-13.1)
No 109(79.6) 269(98.2) 1 1
Reminder use
Yes 127(92.7) 268(97.8) 0.3(0.1-0.8) 0.5(0.1-2.0)
No 10(7.3) 6(2.2) 1 1
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Table 3(Continued): Determinants of non-adherence to ART among HIV-infected adults
in Aksum town health facilities, Tigray Regional State Ethiopia 2015.
Explanatory
variables
Adherence status to ART COR(95%CI) AOR(95%CI)
Non-adherent
Number (%)
Adherent
Number (%)
Stigma
Yes 17(12.4) 10(3.6) 3.7(1.7-8.4) 2.8(0.9-8.5)
No 120(87.6) 264(96.4) 1 1
WHO stage
stage I 16(11.7) 68(24.8) 1 1
stage II& above 121(88.3) 206(75.2) 2.5(1.4-4.5) 1.6(0.8-3.5)
BMI
Under weight 38(27.7) 41(15) 1 1
Normal 97(70.8) 224(81.7) 0.5(0.3-0.8) 0.7(0.3-1.3)
Over weight 2(1.5) 9(3.3) 0.2(0.1-1.2) 0.4(0.0-3.0)
Treatment other
than ART
Yes 41(29.9) 40(14.6) 2.5()1.5-4.1) 1.4(0.7-3.0)
No 96(70.1) 234(85.4) 1 1
**P – value < 0.05
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6. DISCUSSION
One of the foremost concerns of ART programs is the ability of people living with
HIV/AIDS to maintain near perfect adherence over the long term. Both patients and
health care providers face significant challenges with respect to adherence to
ART(6).
In our finding, those who were on ART for more than two years had 7 times higher
probability  of being non-adherence compared to those have been on ART for 6-12
months and the  association was significant. The reason could be due to HIV
infected patients on ART for long time may become complacent and find it harder to
follow the strict regimen and also it might be because of they were bored of taking
the medication. This finding is agreed with studies in Ethiopia (Harari and Yirgalem
Hospitals)(14, 22) and Lao PDR(18).The other possible contributing factor in
decreased ART adherence over time could be due to family members who had
initially played a role in helping patients take their medication might be  assumed the
client on ART was taking their medication as prescribed and followed up with the
client less regularly. But contradicts  with the findings in Asia(36) and Nepal(19)
which reported patients who have been on ART for short period  were more likely to
be non-adherent. The possible difference could be due to those studies included
study participants with less than 6 months duration on ART and thus HIV infected
adults on ART at early phase of treatment may face difficulty of adhering until they
familiarize with ART.
Presence of medication adverse effect had statistically significant association with
increasing non-adherence to ART. This may be due to the adverse effects and
toxicity of the complex ART drugs which could be associated with non-adherence to
ART. This is supported by studies in northwest Ethiopia (13) which identified those
who had ART adverse effects were non-adherent to ART than that of without
adverse effects. As studies reported  in Asian developing countries in 2012  ART
drugs have toxicities and adverse side-effects that can prevent adherence to ART
(35). However the finding of this study is inconsistent with studies done in
northwest(5) and Southern Ethiopia (17),Nairobi Kenya(25) and Lao PDR(18), which
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showed adverse effect had no significant association with non-adherence to ART.
This inconsistency may be due to the difference of study design used.
Non-adherence to ART was significantly associated with substance use. Non-
adherence was higher among substance users compared to non users. Some
participants may stopped taking medication because they believe that one should
not drink alcohol at all (not even incidentally and moderately) while on ART. Hence,
since alcohol drinking is common in the study area, they might skip medication even
when they drunk a moderate amount of alcohol on a particular occasion.
Furthermore, substance use (alcohol use, cigarette smoking and chat chewing) can
result into forgetfulness of ART doses. This finding is consistent with studies in
southern Ethiopia (17), Tanzania(31) and Nepal(19).
The odd of non-adherence was 3.4 times higher among those who live with their
parents compared to that of individuals who live alone and had significant
association with facilitating non-adherence to ART. This may be due to the reason
that clients may not be comfortable to take ART dose in front of others.
Inconsistence to our finding, In Canada individuals living with someone were less
non-adherent  compared to that of with those who live alone(29). The difference may
be due to clients’ self-efficacy and attitude towards ART medication.
Having depression symptom was found to be a risk factor for non-adherence to ART
and was significant. Consistent with the existing literatures in southwest
Ethiopia(15), South Africa(33) and Netherlands(32), the presence of depressive
symptoms proved to be a barrier to ART adherence in this study. This finding sheds
light on the complexity between the associations of depressive symptoms with ART
non-adherence. Another possible explanation could be those clients with depressive
symptoms may easily forget taking their dose.
CD4 count less than 350 was 3.2 times more prevalent in the non-adherents
compared to the adherents and it had significant association in increasing non-
adherence to ART. This might be due to patients with lower CD4 counts and less
perceptions of their health are likely to have witnessed less improvement in their
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health as a result of commencing ART. This might be facilitated non-adherence to
ART. The finding is supported by studies in north Ethiopia(16), South Africa(33) and
systematic review in Cameron(20), which showed that high CD4 cell count was
associated with decreasing non-adherence to ART. However it is controversial with
study done in Yirgalem Hospital, Ethiopia in which participants who had high CD4
counts were more likely at risk of non-adherence to ART than those who had less
CD4 count (22). This could be attributed to improvement of health status of the
clients on ART, thus making him/her careless and casual in their approach to ART
and this reason was supported  by studies in Delhi, India (37).
Those who had low dietary diversity were 2 times more likely to be   non-adherent
compared to those of who had medium and above dietary diversity. The possible
explanation could be some patients might have been taught and believed that ART
drugs always need to be taken with food and some might have missed the
medication as they missed their meal due to the food/dietary insufficiency. This is
supported by findings in south and north Ethiopia(16, 17) and Zambia(21).
We found no evidence that sex had a significant influence on ART non-adherence.
But cross sectional study in southern Ethiopia(22)and systematic review in
Cameroon(20) showed females were less likely at risk of non-adherence to ART
than male patients. This may be due to gender gap in access to supportive HIV
services, such as targeted counseling and programs for the prevention of mother-to-
child HIV transmission offered by antenatal services.
Though this research did not showed significant association between occupation
and non-adherence to ART,  meta-analysis from each14 developing and developed
countries showed  patients with HIV infections who were employed were more likely
to adhere to ART than those who were unemployed(28). It is possible that
employment can facilitates adherence to HIV treatment because it can be
associated with improved psychosocial well-being. Employment may also promote
increased material well-being by improving food security and housing quality that
can be associated with adherence to HIV treatment.
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7. LIMITATION
The findings of this study should be interpreted with some limitations. Despite this
case control study provides statistical association on factors associated with non-
adherence to ART, it cannot establish whether these factors are causative or not.
Some variables (e.g. dietary diversity, meal frequency, depression symptom) were
collected by allowing participants freely to recall past events so this self report of
past events could have been introduced recall bias.
The use of ART clinic nurses and case managers as data collectors might have
been introduced an interviewer bias during interviewing past events.
8. CONCLUSION
In this study long duration on ART (more than two years), experiencing adverse
effect of ART, substance use, living with parents, having depression symptom, low
CD4 cell count (less than 350 cells/mm3) and low dietary diversity were identified as
a risk factors for non-adherence to antiretroviral therapy.
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9. RECOMMENDATIONS
For government and policy makers: For those who have food insufficiency, in
addition to distributing food supplementation, income generating activities need to be
integrated as ART adherence improvement strategies to improve their dietary
quality based on local context and to reduce ART non-adherence among PLWHA.
For health care workers: For those PLWHA who stayed on ART for long duration,
health care providers have to give much attention to client’s situation on following
ART because they may be bored of taking medication.
The management of ART adverse effects is a vital part of successful ART
adherence. Hence, it is necessary to discuss all potential adverse effects with clients
before they begin ART to provide treatment for adverse effects.
Health care providers need to ensure that all clients are exposed to continuous
counseling in order to avoid substance use, develop clients’ self-efficacy on taking
ART in front of others and there should be attempts to improve access to mental
health care for those screening positive for depression symptoms.
When clients have lower CD4 counts/mm3, time should be dedicated with every
patient to counsel/ educate that they should keep taking their ART medication.
For researchers: Further research preferably longitudinal designs needed to be
conducted to understand deeply for factors associated with non- adherence to ART
because ART adherence is dynamic and its factors are modifiable from time to time.
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11. ANNEXES
Annex-I Co-linearity diagnostic test between independent variables.
Independent variable Variance inflection factor VIF 1/VIF
Duration on  ART
6-12 month(reference category)
13-24 month 2.00 0.50
>=25 month 2.09 0.47
Treatment other than ART 1.30 0.91
Substance use 1.10 0.85
Stigma/discrimination 1.68 0.6
Residence 1.39 0.72
Adverse effect of ART 1.76 0.57
Opportunistic  infection 1.73 0.58
Age in years
18-29(reference category)
30-39 2.26 0.44
40-49 2.09 0.48
>=50 1.57 0.64
Client lives with
Alone (reference category)
Parents 1.37 0.73
Families 1.36 0.73
Eating pattern 1.14 0.88
Dietary diversity 1.25 0.88
WHO staging 1.17 0.86
CD4 count 1.12 0.90
Depression symptom 1.44 0.70
Reminder use 1.13 0.88
Mean VIF 1.59
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Annex - II: Consent form in English language
Institute of Public Health Department of Epidemiology and Biostatistics, collage of
Medicine and Health Science, University of Gondar study questionnaire on the
determinants of none-adherence to Antiretroviral Therapy among HIV infected adults
in Aksum town health facilities, Tigray, Ethiopia, 2015.
Dear madam/sir good morning /good afternoon
My name is __________________________________.I am working as data
collector in research project, which is conducted by University of Gondar. The aim of
this study is to identify determinants of none-adherence to antiretroviral therapy
among adult People Living with HIV/AIDS in Aksum town health facilities, Tigray,
Ethiopia. Identifying these factors will help to design and implement an intervention
to improve treatment adherence of ART clients to their medication.
Since you are taking ART, I would like to ask you some questions concerning this
study. The information you will be giving me will be used only for study purpose and
your name, identification number and address are not required. All your personal
information will be confidentially treated.
To fill this questionnaire it will take from 15-20 minutes. You have all the right to
refuse to answer to any of the questions and withdraw at any time.
If you are interested to participate, will you sign here please?
1. Yes, (if say yes thanks and continue with her)
2. No, (if say no thanks and skip her)
Participant’s signature ----------------------------------
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Annex -III:   Information sheet in English language
Title of the Research Project: To identify determinants of none-adherence to
antiretroviral therapy among adult People Living with HIV/AIDS in Aksum town
health facilities, Tigray, Ethiopia, 2015
Name of Principal Investigator: Berhe Beyene
Name of the Organization: University of Gondar College of Medicine and Health
Sciences, institute of Public Health Department of Epidemiology and Biostatistics
Information sheet and consent form prepared for persons who are going to
participate in this research project.
Introduction
This information sheet and consent form is prepared with the aim of identifying
determinants of none-adherence to antiretroviral therapy among adult People on
ART. The research group includes the principal investigator, three data collectors,
two supervisors, and two advisors from University of Gondar.
Purpose of the Research Project
The aim of this study is to identify determinants of none-adherence to antiretroviral
therapy among adult People on ART in Aksum town health facilities, Tigray,
Northern Ethiopia, 2015 which is essential to formulate a better new policy strategies
and intervention measures. The results of this study will be used to design
appropriate intervention programs to address the none-adherence to antiretroviral
therapy among adult People on ART during their medication.
Procedure
This study involves adult people on ART. You are randomly selected to be one of
the study participants if you are willing to take part in this study; we kindly invite you
to take part in our project. If you are willing to participate, we are so happy and we
need you to clearly understand the aim of this study and to sign the consent form.
Finally you are kindly requested to give your genuine response in the interview
questionnaire. You do not need to tell your name to the data collector and all your
responses and the results obtained will be kept confidentially by using coding
system whereby no one will have access to your responses.
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Benefits,
By participating in this research project you may feel some discomfort in wasting
your time (a maximum of 20minutes) .However, your participation is definitely
important to the level ART utilization and its associated factors so as to design
appropriate strategy and intervention to enhance adherence to ART. The result will
be disseminated to University of Gondar College of Medicine and Health Science,
institute of public health, Tigray Regional Health Bureau and hospitals of Central
zone Tigray.
Risk and /or Discomfort; there is no risk or direct benefit in participating in this
research project.
Incentives/Payments for Participating
You will not be provided any incentives or payment to take part in this project.
Confidentiality
The information collected from you will be kept confidential and stored in a file,
without your name by assigning a code number to it. And it will not be revealed to
anyone except the principal investigator and will be kept locked with key
Right to Refusal or Withdraw
Participating and not participation is the full right participants and they can stop
participating in the study at any time. They can also skip any question which they
want to respond. They can ask any question which is not clear for them.
Person to contact
This research project will be reviewed and approved by the ethical committee of the
University of Gondar. If you have any question you can contact any of the following
individuals and you may ask at any time you want.
a)   Name: Berhe Beyene: Telephone: +2519 10893579
b) Professor Yigzaw Kebede (MD, MPH, Telephone +251 913 99 79 33
c) Mr.Yalemzewod Assefa (MPH): Telephone +251911568477
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Annex- IV. Consent form
I have been informed that the purpose of this study is to identify determinant factors
of non-adherence to ART among adults on ART. I have understood that participation
in this study is entirely voluntarily. I have been told that my answers to the questions
will not be given to anyone else and no reports of this study ever identify me in any
way. I have also been informed that my participation or non-participation or my
refusal to answer questions will have no effect on me. I understood that participation
in this study does not involve risks.
Respondent’s signature_________________________________
If no, skip to the next participant
Date of interview: _________ Time started: ______, Time finished: ______
Interviewer
Name_________________________Signature___________Date____________
Supervisor’s name ________________ signature ________
Annex –V: Structured English version questionnaire
University of Gondar College of Medicine and   Health   Science, Institute of Public
Health questionnaire on determinant factors of non adherence to ART among adults
on ART in Aksum town health facilities, Tigray, Ethiopia, 2015
Section I: Questions on socio-demographic and economical factors
No, Questions Coding categories Skip
101 Sex 1,male 2,female
102 Age in years ---------------
103 Religion 1,Orthodox
2,Muslim
3,Other specify-------------
104 Ethnicity 1,Tigray 2,Amhara
3,Oromo
4, Other specify ---------
105 Residence 1,Urban 2,Rural
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106 Marital status 1,single 2,Married
3,Widowed 4,Divorced
5,separated
107 Educational status --------
108 Distance from health facility in K/m ----------
109 Occupation type 1,no occupation
2,government employed
3,busnes/self employed
4.farmer
5,Daily laborer
6,other ----------
110 Monthly income in ETB ---------
Section II: Questions on nutrition related factors
111 During the previous 24 hours period (yesterday and night)did you consume the
following?(circle all that you apply)
1. Any bread, rice noodles, biscuits, or any other foods made from millet,
sorghum, maize, rice, etc?
2. Enjera made from whole grains like wheat, sorghum, teff, corn etc?
3. Any vegetables, any meat like beef, chicken, liver, kidney, heart, or other
organ?
4. Any eggs?
5. Any fresh or dried fish or shellfish?
6. Any foods made from beans, peas, lentil, or nuts, any cheese, yogurt, milk,
or other milk products?
7. Ay foods made with oil, fat, or butter?
8. Any sugar or honey?
9. Any other foods, such as condiments coffee, or tea?
112 Daily eating pattern of last 12 months
1. Three meals & above
2. Two meals & eating between meals
3. Two meals or less
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Section III: Questions on medication related factors
113 For how long have you been on ART? 1. ,6-12 months
2. 13-24 months
3. >=24 months
114 How many times did you take your medication
per day?
1. Once
2. Twice
3. Three times
4. Four times
115 Are there are any other medications that you are
taking?
1. Yes
2. No
if no
skip
to Q
117
116 If yes to question 115, what types of medications
are taking?
1. Traditional
2. Modern
117 Methods to remember drug medication time 1.mobile, 2.watch 3.Televsion,
4.Gusing
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125 Reasons for missing doses 1. Toxicity-Side effect
2.  Shared with others
3. Simply forget
4. Felt better/Too ill
6. Poor interaction with health
care provider
7. Drug out of stock(health
facility)
8. Patient run out of stock/lost
them
9. Alcohol
10. Fasting
11. Start other treatment
12. Away from home
13. Too many pills
14. Long waiting time
15. Missed appointment 16.
Stigma/discrimination
17. Others specify---------
Section IV: Questions on psychosocial factors
118 Whit him do you live? 1. Live alone
2. With my parents
3. With family
4. Unstable
5. Other specify -------
119 Have your partner tasted for HIV 1.Yes 2.No 3.Do not know
120 your partner HIV status 1.Negative 2.positive
3.Do not know
121 Do you disclose your HIV status to your partner? 1. Yes
2. No
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122 Do you disclose your HIV status to others? 1.Yes
2.No
123 Do you have any emotional and practical
support?
1. Yes             2. No If no
skip
to
Q126
124 If yes to question 123, who supports you? 1. Family
2. friends/peers
3. home based care
providers / community
4. health care providers
5. mother to mother support
group
125 What type of support do you get from your
supporters?
1. material/financial
2. information/advice
3. social/moral
4. others specify
126 Do you have history of active substance use
currently?
1.Yes 2.No If no
skip
to Q
126
127 If yes to question 126 which substance do you
use?
1.alcohol 2.cigarette 3.chat
4.Others specify----------
128 How often do you use alcohol? 1. Every day
2. Nearly every day
3. 3 to 4 times a week
4. 2 times a week
5. Once a week
6. 2 to 3 times a month
7. Once a month
129 Do you smoke cigarette currently (within 30
days)?
1. Yes
2. No
130 Do you feel you are excluded from any social 1. Yes
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gathering (weeding, funeral, party and
community association group)?
2. No
131 Over the last two weeks how often have you
been bothered by any of the following
problems?(CIRCLE ONE NUMBER ON EACH
LINE)
Not
at
all
Severa
l days
More than half
the days
Ne
arl
y
ev
er
y
da
y
1.Little interest or pleasure in doing things 0 1 2 3
2.Feeling down, depressed or hopeless 0 1 2 3
3.Trouble falling or staying asleep or sleeping
too much
0 1 2 3
4.Feeling tired, or having little energy 0 1 2 3
5.Poor appetite or overeating 0 1 2 3
6.Trouble concentrating on things 0 1 2 3
7.Feeling bad about myself 0 1 2 3
8.Moving or speaking so slowly that other people
could have noticed
0 1 2 3
9.Thoughts that I would be better off dead ,or of
hurting myself
0 1 2 3
Total score
THANK YOU! I have finished my interview if you have any question on ART?
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Section V: Factors from ART follow up charts of the last three visits among adults
on ART in Aksum town health facilities, Tigray, Ethiopia, 2015
S.N Factors included in ART follow up form Last three visits
1 Adherence status
2 Duration on ART
3 Side effect/write all that apply
4 Reasons for stopping regimen/ write all that apply
5 symptom screen/ write all that apply
6 Opportunistic infection/ symptom 1,
2,
7 Dispense dose/regimen
8 WHO staging
9 CD4 cell count in cells/mm3
9 Therapeutic /supplementary feeding 1,yes
2,no
10 BMI(kg/m2
11 HGB(mg/dl)
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ANNEX-VI: መብርሂ ቅድመ መሕትት
ጎንደር ዩንቨርስቲ ኮሌጅ ሕክምናን ጥዕና ሳይንስን ክፍሊ ትምህርቲ ኢፒደሞሎጀይ ኤንድ
ባዮስታስቲክስ መፅናዕቲ ምስ ፀረ ኤች አይቪ መድሓኒት ዘይምውሳድ ዝተተሓሓዙ ተዛመድቲ
ጉዳያት ኣብ ማእከላይ ዞባ
ሰላም- ከመይ ውዒለን/ኩም
አነ ሽመይ----------------------------------------------------ይባሃል፡፡ ኣብዚ ዕለት እዚ ኣብዚ ዝተረከብኩሉ
ምክንያት ኣብ ፀረ ኤች አይቪ መድሓኒት ምውሳድን ተዛመድቲ ጉዳያትን ሐበሬታ ንምእካብ እዩ፡፡
ፅንዓቱ ዝካየድ ብኣቶ በርሀ በየነ እንትኸውን ኣብ ጎንደር ዩንቨርስቲ ኢፒደሞሎጀይ ኤንድ
ባዮስታስቲክስ ክፍሊ ትምህርቲ ናይ ካልአይ ዲግሪ ተምሃራይ እዩ፡፡
ዕላማ ናይዚ መፅናዕቲ ኣብ ከተማ ኣክሱም ጥዕና ድርጅታት ዝርከቡ/ባ ምስ ፀረ ኤች አይቪ
መድሓኒት ብኣግባቡ ዘይምውሳድ ዝተተሓሓዙ ተዛመድቲ ጉዳያት ንምፍታሽ እዩ፡፡ ኣብዚ መፅናዕቲ
ንክትሳተፋ/ፉን ትክክለኛ ሐበሬታ ክትህባ/ቡን ብትሕትና ይሐትት፡፡ ናትክን/ኩም ምትሕብባርን
ድሌትን ኣብዚ ዝግበር መፅናዕቲ ኣብ ፀረ ኤች አይቪ መድሓኒን ብኣግባቡ ዘይምውሳድን ተዛመድቲ
ጉዳያትን ዘለዉ ፀገማት ንምፍላይ ኣዝዩ ጠቃሚ እዩ፡፡ እዚ መፅናዕቲ ብቃለ መሕትት ዝካየድ ኮይኑ
ንኣስታት 15 -20 ደቒቓ ግዜክን/ኩም መስዋእቲ ንክትገብራ/ሩለይ ይላቦ፡፡
እዚ መጠይቅ ዝምላእ ብዝሰልጠነ ሐታታይ ክከውን ከሎ አብ ኩሉ ከይዲ ምምላእን ሐበሬታታት
ምስጢሩ ዝተሐለወ ምኻኑ ከረጋግፅ ይፈቱ፡፡ ናይ ውልቀ ሰባት መልሲ ዝተሓዝ ብዝወሃብ ኮድ
ቁፅሪ ክኸውን ከሎ ናይ ውልቀ ሰብ ሽም ይኹን አድራሻ አይተሐዝን፡፡ ውፅኢት እውን ዝግለፅ
ብጥቅሉል እምበር ናይ ውልቀ ሰባት ዝግለፅ አይኮነን፡፡
እዚ ቃለ መሕትት ብድሌት ጥራሕ ዝግበር እዩ፡፡ ስለዚ አብዚ ሕቶን መልስን ብምስታፍክን/ኩም
ኮነ ብዘይምስታፍክን/ኩም አብ ቀፃሊ ንባዕልክን/ኩም ይኩን አብ ስድራክን አብ ዘድልየክን/ኩም
አገልግሎት ዝፈጥሮ ምንም ዓይነት ፅዕንቶ ከምዘየለ የረጋግፅ፡፡ ኣብ ዝቀርብ ሕቶ ጥርጣረ
እንተሓዲሩወን/ኩም ኣብ ዝኮነ እዋን ናይ ምቁራፅ መሰለን/ኩም ዝተሐለወ እዩ፡፡ ነዚ መፅናዕቲ
ዝምልከት ሕቶ እንተለወን/ም ወይ ድማ ናይዚ መፅናዕቲ ውፅኢት ክፈልጣ/ጡ እንተደልየንዮም
ከይተሰከፋ/ፉ ንበዓል ዋና እዚ መፅናዕቲ ብዝስዕብ ኣድራሻ ምጥያቕ ይክእላ/ሉ እየን/ዮም፡፡
ኣድራሻ በዓል ዋና መፅናዕቲ
በርሀ በየነ ቁፅሪ ሞባይል- 251 910893579, ኢ. መይል:
berhebeyene2005@gmail.com
1. እወ------------------------------------------------ ናብ ዝቅፅል ገፅ ቀፅል/ሊ
2. አይፋለይን------------------------------------------ናብ ዝቅፅል ተሳታፋይ ቀፅል/ሊ
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Annex-VII: ሰነድ ብዛዕባ ሓበሬታ መፅናዕቲን መሕተቲ ስምምዕነትን
ምስ ፀረ ኤች አይቪ መድሓኒት ዘይምውሳድ ዝተተሓሓዙ ተዛመድቲ ጉዳያት ኣብ ከተማ ኣክሱም
ጥዕና ድርጅታት ንምፅናዕ ዝተዳለወ ሰነድ ሓበሬታ፡፡
ዋና ፅንዓት መካየዲ፡ በርሀ በየነ
ሽም ትካል፡ ጎንደር ዩንቨርስቲ ፤ጎንደር ሕክምናን ጥዕና ሳይንስን ኮሌጅ፤ሓለዋ ጥዕና ሕብረተሰብ
ክፍሊ ትምህርቲ ኢፒደሞሎጀይ ኤንድ ባዮስታስቲክስ
ወፃኢ ዝሽፍን ትካል፡ ጎንደር ዩንቨርስቲ
መእተዊ፡ እዚ ሓበሬታንመሕተትን ስምምዕነት ሰነድ ንምስታፍ ንሓተሉ መብራህርሂ ሰነድ
እዩ፡፡ንምስታፍ ቅድሚ ምውሳነን በቶም ሓበሬታ አከብቲ ሰነድ ይንበብ፡፡ ብፅሞና ብምድማፅ
ዘይተረደአን ወይ ግልፂ ዘይኮነ ነገር ቅድሚ ስምምዕነት ተሳትፎ ምጅማር ምሕታት ይካአል እዩ፡፡
ከምኡ ውን ምስታፍ ምስ ጀመራ ግልፂ ዘይኮነ አብ ዝኮነ ግዚ ምሕታት ይካአል እዩ፡፡
ዕላማ መፅናዕቲ፡ ናይዚ መፅናዕቲ ዋና ዕላማ ፅንዓት ምስ ፀረ ኤች አይቪ መድሓኒት ብግቡእ
ብዘይምውሳድ ዝተተሓሓዙ ተዛመድቲ ጉዳያት ንምፅናዕ እንትከውን ዝተፈላለዩ መፍትሒ እቲ
ፀገም ንምንፃር ዓብይ እጃም አለዎ፡፡ብተወሳኪ ብዝሐሸ መንገዲ ንምፅናዕ አንፈት ንምምልካት
ይሕግዝ፡፡ስለዚ ተሳተፍቲ እዚ መፅናዕቲ ንክትኮኑ/ና ተዓዲሞም/መን አለዋ ፡፡ ዕላማ መፅናዕቲ
ብምርዳእ ንምስታፍ እንተተሰማዕሚዖም/ዐን፤ ምስምዕምዖም/ዐን ብፅሑፍ ይግለፁ/ፃ፡፡ ብምቅፃል
ሓበሬታ ንምስብሳብ ቃለ ማሕትት ብአከብቲ ሓበሬታ ክካይድ እዩ፡፡ሽሞም/መን ምንጋር አየድልን፡፡
መልሶም/ስን ምስጥራዊ እዩ፡፡
ሓደግታት ወይ ድማ ምምችቻው፡ አብዚ መፅናዕቲ ብምስታፎም/ፈን ዘይምምችቻው ክስመዖም/ዐን
ይክእል እዩ፡፡ብፍላይ 20 ደቂቃ ዝአክል ግዚ ክሻመይ ይክእል እዩ፡፡ ነገር ግን ፅንዓት ካብ ዝህቦ
ጥቅሚ አንፃር ከም ትሳተፉ/ፋ ተስፋ ንገብር፡፡ አብዚ መዕናፅቲ ብምስታፎም/ፈን ሓደጋ የብሉን፡፡
ክፍሊት፡ አብዚ መፅናዕቲ ብምስታፎም/ፈን ዝክፈል ክፍሊት የለን፡፡
ምስጥራዊነት፡ነዚ መፅናዕቲ ዝተአከበ ሓበሬታ ብምስጥር ዝተሓለወ እዩ፡፡ እቲ ዝእከብ ሓበሬታ አብ
ፋይል እንትትሓዝ ሽመካ ምስኡ አይፀሓፍን፡፡ነገር ግን መለለይ ቁፅሪ ክግበረሉ እዩ፡፡ እቲ ሓበሬታ
አብ ናይ ዋና መፅንዒ ፋይል ጥራሕ ተቖሊፉ ስለ ዝቅመጥ ማንም ሰብ ክረክቦ አይክእልን፡፡
መሰል ምቁራጽ አብ ከይዲ ቃለ መሕትት፡ አብዚ መፅናእቲ ናይዘይምስታፍ ሙሉእ መሰል
አለዎመ/ወን፡፡ምምላስ ዘይደልይዎም/ኦም ሕቶታት ናይ ዘይ ምምላስ መሰል አለዎም/ወን፡፡ አብ
ዝኮነ ግዜ ናይ ምቁራፅ መሰል አለዎም/ወን፡፡ ብዛዕባ እቲ መፅናዕቲ ሓበሬታ ንምሕታት
እንተደሊዮም/የን ምስ እዞም ዝስዕቡ ሰባት ክራከቡ/ባ ይክእሉ/ላ እየን፡፡
1. አቶ በርሀ በየነ ቁፅሪ ስልኪ +2519 10893579
2. ፕሮፌሰር ይገዛው ከበደ ቁፅሪ ስልኪ +251 913 99 79 33
3. ኣቶ ያለምዘዎድ ኣሰፋ ቁፅሪ ስልኪ +251911568477
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ANNEX- VIII: ናይ ስምምዕነት ቅጥዒ ቅድመ መፅናዕቲ ሕቶን መልስን
ኣብ ከተማ ኣክሱም ጥዕና ድርጅታት ኣብ ዝርከባ ጥዕና ትካላት ምስ ፀረ ኤች አይቪ መድሓኒት
ብግቡእ ብዘይምውሳድ ዝተተሓሓዙ ተዛመድቲ ጉዳያት ብዝብል ስያሜ ኣብ ዝካየድ መፅናዕቲ
ንምስታፍ ዝተሰማማዕኹ ኮይነ፣ ነዞም ዝስዕቡ ዋኒናት ኣብ ግምት ብምእታው እዩ፡፡
ዕላማ ናይዚ መፅናዕቲ ኣብ ከተማ ኣክሱም ምስ ፀረ ኤች አይቪ መድሓኒት ብግቡእ ብዘይምውሳድ
ዝተተሓሓዙ ተዛመድቲ ጉዳያት ንምፍታሽ ምኻኑ ብምርዳእ፣ እዚ ቃለ መሕትት ብድሌት ጥራሕ
ዝግበርን ምሽጥሩ ዝተሓለወን ምኻኑ ብምእማን ከምኡ ውን ምስታፈይ፣ ዘይምስታፈይ ወይ
ምንፃገይ ኣባይ ምንም ዓይነት ተፅዕኖ ከምዘይብሉ ኣብ ግምት ብምእታው፣ ኢሉ ውን ኣባይ ዘምፅኦ
ሳዕቤን ከምዘየለ ብምርዳእ፣ ኣብ መወዳእታ እውን ነዚ
መፅናዕቲ ዝምልከት ሕቶ እንተለኒ ወይ ድማ ናይዚ መፅናዕቲ ውፅኢት ክፈልጥ እንተደልየ ንበዓል
ዋና እዚ መፅናዕቲ ኣቶ በርሀ በየነ ኣብ ላዕሊ ብዝተጠቀሰ ኣድራሻ ምጥያቕ ከምዝክእል ብምእማን
፤ ኣብዚ መፅናዕቲ ንምስታፍ ፍቃደኛ እየ፡፡
ናይ ተሳታፋይ/ፊት ፊርማ --------------------------------
ፍቃደኛ እንድሕር ዘይኮይነን ናብ ዝቅፅል ተሓታታይ ይሕለፉ/ፋ
ዝተሐተተሉ ዕለት-------------------ዝተጀመረሉ ሰዓት-----------------ዝተወደአሉ ሰዓት-------------
ናይ ሐታታይ ሽም---------------------------------------------------- ፊርማ-----------------
ሽም ተቆፃፃሪ-------------------- ፊርማ-----------------
ውፅኢት ቃለ መሕትት
1. ዝተማልአ 2. ዝተነፀገ 3. ዘይተማለአ
Annex – IX: ናይ ትግርኛ መሕተቲ ፎርም
አብ ጎንደር ዩንቨርስቲ ጎንደር ሕክምናን ጥዕና ሳይንስን ኮሌጅ ምርምር ማዕከል ሓለዋ ጥዕና
ሕብረተሰብ ክፍሊ ትምህርቲ ኢፒደሞሎጀይ ኤንድ ባዮስታስቲክስ ብ 2007 ዓ/ም ኣብ ከተማ
ኣክሱም ጥዕና ድርጅታት ምስ ፀረ ኤች አይቪ መድሓኒት ብኣግባቡ ብዘይምውሳድ ዝተተሓሓዙ
ተዛመድቲ ጉዳያት ንምፅነዕ ዝተዳለወ መሕተቲ
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መዘኻኸሪ- ካብቶም መማረፅታት ሕረዪ፤ ካሊእ ሓሳብ እንተሃልዩ ኣብቲ ክፍቲ ቦታ ይፀሓፍ
ተ.ቁ ሕቶታት መልሲ ክኮኑ ዝክእሉ ኣማረፅታት ይሕለፉ/ፋ
ክፍሊ1 ፡ምስ ፀረ ኤች አይቪ መድሓኒት አጠቃቅማ ዝተተሓሓዙ ሕቶታት
101 ንክንደይ ዝአክልግዜ ናይ ፀረ ኤች አይቪ
መድሓኒትተጠቂሞም/መን?
1. ካብ 6-12 ወርሒ
2. ካብ 13-24 ወርሒ
3. >=25 ወርሒ
102 አብዚ ሕዚ ግዜ ኣብ መዓልቲ ክንደይ ግዜ ናይ ፀረ ኤች
አይቪ መድሓኒት ይወስዱ/ዳ ኣለዉ/ዋ?
1. ሓደ ግዜ
2. ክልተግዜ
3.ሰለስተንካብኡ ንላዕሊን
4. ኣይፈልጦን
103 ካብ ፀረ ኤች አይቪ መድሓኒት ወፃኢ ዝጥቀሙዎም/ኦም
መድሓኒት ኣለዉ ዶ?
1.እወ
2.የለን
መልሶም የለን
እንተኮይኑ ናብ ቁ
105. ይሕለፉ
104 ንቁፅሪ 103 መልሶም/ሰን እወ እነተኮይኑ እነታይ ዓይነት
መድሓኒት ይጥቀሙ/ማ?
1. ባህላዊ
2. ዘመናዊ
3. ካሊእ ይገለፅ
1o5 መድሓኒት ትወስደሉ ሰዓት ንምስትወስ እንታይ
ትጥቀም/ሚ
1. ሞባይል 2.ሰዓት
3. ካሊእ የገለፅ-------------
106 ኣብ ዝሓለፉ 6 ወርሒታት ናይ ፀረ ኤች አይቪ
መድሓኒት ምውሳዶም ይርስዑ እንተነይሮም ምክንያቱ
እንታይ ነይሩ ይብሉ?ካብዞም ዝስዕቡ ምክንያታት ሓደ
ወይ ካብ ሓደ ንላዕሊ ምልክት ምግባር ይክእሉ ዕዮም
1.ናይቲ መድሓኒት ጎናዊ
ሳዕቤናት
2.ካልኦት ስለ ዝተጠቀምሉ
ተወዲኡ
3.ረሱአዮ
4.ፅቡቅ ሰሚዒት ስለዝነበረኒ
5.ብከቢድ ስለዝሓመምኩ
6.ምስጥዕና በዓል ሞያ
ስለዘይተሰማዕማዕኩ
7.ኣብ ጥዕና ድርጅት መድሓኒት
ስለዘይነበረ
8.መድሓኒት ስለዝወዳእኩ
9.መጠንመድሃኒት
ብዘይምፍላጠይ
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10.ኣልኮል ስለዝሰተኩ
11.ፆም ስለዝኮነ
12.ካሊእ መድሓኒት
ስለዝጀመርኩ
13.ካብ ገዛ ሪሒቀ ስለዝነበርኩ
14.መድሓኒተ ስለዝበዝሐኒ
15.ምፅባይ ጊዜ ስለዝበዝሐኒ/ኣብ
ጥዕና ድርጂት
16.ቆፀሮ ረሲዐዮ
17.ምግላል/ኣድልዎ
18.ካሊእ ይገለፅ-------
ክፍሊ 2 ብዛዓባ ስርዓተ ምግቢ ዝምልከቱ ሕቶታት
201 ኣብዞም ዝሓለፉ 24 ሰዓታት (ለይቲን መዓልቲን)ካብዞም ዝስዕቡ ምግብታት ኣየንኦም ተመጊቦም?መልሶም
የክብቡ
1. ዳቦ,ሩዝ,ብሽኩቲ ወይም ካልኦት ካብ ጣፍ መሸባሕሪ ወዘተ ዝተሰርሑ ምግብታት
2. አትክልቲ
3. ፍራፍሬ
4. ፀብሒ ደርሆ,ስጋ ዝመሳሰሉ ናይ እንስሳት ተዋፅኦ
5. እንቁላሊሕ
6. ናይ ዓሳ ምግቢ
7. ካብ ዓተር,ዓተባሕሪ፣ዝመሳሰሉዝተሰርሑ ምግብታት
8. ናይፀባ ተዋፅኦ ከም ርግኦ,ዝመሳሰሉ ምግብታት
9. ብስብሒን ጠስሚንዝተሰርሑ ምግብታት
10. ሽኮር ወይም መዓር
11. ካልኦት ተወሰክቲ ምግብታት ከም ሻሂ ቡና ዝመሳሰሉ
ካልኦት ምግብታት እንተወሲዶም ይግለፅዎም
202 ካብዞም ዝስዕቡ አየንኦም እዮም ብዝበለፀ ኣብ ዝሓለፈ ወርሒታት ዝነበረ ናይ አመጋግባ
ኩነታቶም ዝገልፁ
1. ሰለስተ ጊዜን ካብኡ ንላዕሊን 2. ክልተ ጊዜን ኣብ ማእከል እናሓወስኩ
ይበልዕ
3. ክልተን ካብኡ ንታሕቲን
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203 ትማሊ ብሃይማኖትህ/ሽ መሰረት ፆምካ ዶ ነይርካ/ኪ 1.እወ
2.የለን
ክፍሊ 3፡ ስነ-ኣእምራን ማሕበረዊን ኩነታት
301 ምስመን እዮም/የን ዝነብሩ/ራ? 1. ንበይነይ 2. ምስወለደይ
3. ምስስድራይ 4.
ኣይተረጋጋዕኩን
5. ካሊእ እንተኮይኑ ይግለፅዎ
302 በዓል ሓዳሮም/ረን ናይ ኤችኣይቪ ኤድስ ምርመራ ዶ
ገይረን?
1. እወ 2. የለን ካብ ቁ 302-304ንባዓል ሓዳር
ጥራሕ
303 ናይ በዓል ሓዳሮም/ረን ናይ ኤችኣይቪ ኤድስ ኩነታት 1.ነጌቲብ 2.ፖዘቲብ
3.አላውቅም
304 ብዛዕባ ናይ ኤችኣይቪ ኤድስ ኩነታቶም/ክን በዓል
ሓዳሮም/ረን ይፈልጡ/ጣ ዶ?
1. እወ
2. የለን
305 ብዛዕባ ናይ ኤችኣይቪ ኤድስ ኩነታቶም/ክን ካልኦት
ሰባት ካብ ቤ/ሰብ ወፃኢ ይፈልጡዶ?
1.እወ 2.የለን 3.ኣይፈልጥን
306 ብስነ-ኣእምሮ ኮነ ብተግባር ዝድግፎም/ፈን አካል ዶ
ኣሎ?
1.እወ 2.የለን መልሶም የለንእንተኮይኑ ናብ ቁ
309 ይሕለፉ
307 ንሕቶ ቁ 306 መልሶም/ሰን እወ እንተኮይኑ መን እዩ
ዝሕግዞም/ን?
1.ቤተሰብ 2.ኣዕርክተይ
2.ገዛንገዛ እናዘወሩ ዝሕግዙ
ኣካላት ሕ/ሰብ 3.በዓል ሞያ
ጥዕና
4.ካሊእ ይግለፅ------------------
308 ካብቶመ ዝሕግዝኩም/ክን ሰባት እንታይ ዓይነት ሓገዝ
ይግበረሎም?
1.ናይ ቁሳቁስ/ገንዘብ
2.ናይሃበሬታ/ምክሪ
3.ናይ ማሕበራዊ/ሞራል
4.ካሊእ
309 ናይ ፀረ ኤች ኣይቪ ኤድስ መድሓኒት ብምዉሳዶም
ብረከቡዎ ናይ ኣካላዊ፤ ኢኮኖምያዊን ስነ-ኣእምረዊን
ጥቅሚ ደሰተኛእየኢሎም ይኣምኑ ዶ ?
1.እወ
2.ደስተኛ ኣይኮንኩን
3. ኣይፈልጥን
310 ከም ኣልኮል፣ጫትን ሲጋራን ዝመሳሰሉ ነገራት ናይ
ምዉሳድ ልማድ ኣለዎም ዶ?
1.እወ
2.የለን
መልሶም የለን
እንተኮይኑ ናብ ቁ
315 ይሕለፉ
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311 ንቆፅሪ-310 መልሶም እወ እንተኮይኑ እንታይ ዓይነት
ልምዲ ዘትሕዝ ነገር እዮም ዝወስዱ?
1.ኣልኮል 2.ጫት 3. ሲጋራ
4.ካሊእ ይገለፅ ---
312 ኣልኮል ዝወስዱ እንተኮይኖም መዓዝ መዓዝ የጥቀሙ? 1.በቢመዓልቱ
2.ኣብ ሰሙን ካብ 3-4 መዓልቲ
3.ኣብ ሰሙን 2 ግዜ
4. ኣብ ሰሙን 1 ግዜ
313 ኣብዚ ወርሒ ዉሽጢ ሽጋራ ኣትኪኮም ዶ ነይሮም/ረን 1.እወ 2.የለን
314 ኣብዚ ወርሒ ዉሽጢ ጫት ናይ ምቅሓም ልምጊ ዶ
ኣለዎም/ን
1.እወ 2.የለን
315 ካብ ማሕበራዊ መስተጋበርት (ከም መርዓ፣ቀብሪ፣ድግስን
እድርን ዝመሳሰሉ)ይገለል አለኩ ኢሎምዶ ይኣምኑ?
1. እወ 2. የለን 3.
ኣይፈልጥን
316 ኣብ ዝሓለፉ 2 ሰሙናት ንክንደይ ዝኣክል ግዜ በዞም
ዝሰዕቡ ሽግራት ይሓስቡ ወይም ይጭነቁ ነይሮም
(ኣብዞም ዝስዕቡ ዝኣመንሉ ሓደ ቁፅሪ የክብቡ)
በዚ ሽግር
እዙይ
ተጠቂዐ
ኣይፈልጥን
ብዝሕ
ንዝበሉ
መዓልቲታ(
3-7
መዓልቲታት
ካብ ፍርቂ
ንላዕሊ
መዓልቲታ
ዳርጋ
ኩሉ
ግዜ
ኣብ ዘከናዉኖም ነገራት ትሑት ድልየት ወይም ደሰተኛ
ዘይምካን ሽግር የጋጥመኒ ነይሩ
0 1 2 3
ናይ ታሕተዋይነት ስምዒት ወይም ናይ ሰሚዒት
ምቅዝቃዝ ወይም ቀቢፀ ተስፋ ይስመአኒ ነይሩ
0 1 2 3
እኩል ድቃስ ናይ ዘይምድቃሰ ሽግር ወይም ካብ እኩል
ንላዕሊ ድቃስ ምብዛሕ
0 1 2 3
ናይ ድካም ሰምዒት ወይም ንምንቅስቃስ ሓይሊ ምንኣስ 0 1 2 3
ድኩም ድሌት ምግቢ ወይም ካብ እኩል ንላዕሊ
ምምጋብ
0 1 2 3
ስለ ባዕለይ ሕማቅ ስምዒት ይስመዓኒ 0 1 2 3
ነገራት ብኣትኩሮት ናይ ምክንዋን ሽግር 0 1 2 3
ካልኦት ሰባት ከስተውዕሉዎ ብዝክእል መልክዑ ብቀሰታ
ምንቅስቃስ ወይም ብቀሰታ ምዝራብ
0 1 2 3
ንባዕልካ ናይ ምጉዳእ ወይም እንተዝሞት ይሕሽ ዝብሉ
ሓሳባት ምሕሳብ
0 1 2 3
ክፍሊ 4፡ ማሕበራዊን ስነ ህዝባዊን ኩነታት
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401 ፆታ 1. ተባዕታይ 2. ኣንስታይ
402 ዕድመ -----------
403 ሃይማኖት 1. ተ/ዶ ኦርቶዶክስ 2. ሙስሊም 3.
ካልእ
404 ብሄለሰብ 1. ትግራይ 2. ኣምሓራ 3. ካልእ
405 ዝነብርሉ/ትነብረሉ ቦታ 1. ከተማ 2. ገጠር
406 ናይ ሓዳር ኩነታት 1. ዘይተመርዐወ/ት 2. በዓልሓዳር 3.
ዝሞተቶ/ታት 4. ዝፈትሐ/ት 5.
ዝተፈላለዩ
407 ደረጃ ትምህርቲ ---------------
408 ዓሚል ካብ ዝነብርሉ/ትነብረሉ ርሕቀት ትካል ጥዕና ብኪ/ሜ----------
409 ሕዚ ዘለዎም/ወን ስራሕ 1. ስራሕ ዘየብሉ/ላ 2. ናይ መንግስቲ
ስራሕተኛ
3. ነጋዴ 4. ሓረስታይ 5. መዓልታዊ
ስራሕተኛ
6. ካልእ ይግለፅ ------------
410 ወርሓዊ እቶት ብብር -----------
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